 CAR T cells targeting GPC2 can eliminate tumors in a metastatic neuroblastoma mouse model.A GPC2-directed antibody-drug conjugate (ADC) is capable of killing GPC2-expressing neuroblastoma cells.Glypicans can modify cell signaling pathways and contribute to cellular proliferation and tissue growth.